MANTOVANI, GIOVANNA
MANTOVANI, GIOVANNA
Dipartimento di Scienze Cliniche e di Comunità
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
2025 R. Catalano, E. Nozza, B. Altieri, E. Esposito, G.A. Croci, A.M. Barbieri, D. Treppiedi, S. Di Bari, O. Kimpel, M. Detomas, M. Tamburello, M.P. Schauer, S. Herterich, A. Angelousi, M. Luconi, L. Canu, G. Nesi, C. Hantel, S. Sigala, L. Landwehr, G. Di Dalmazi, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, C.L. Ronchi, G. Mantovani, E. Peverelli
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells
2024 G. Di Muro, R. Catalano, D. Treppiedi, A.M. Barbieri, F. Mangili, G. Marra, S. Di Bari, E. Esposito, E. Nozza, A.G. Lania, E. Ferrante, M. Locatelli, D. Modena, C. Steinkuhler, E. Peverelli, G. Mantovani
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes
2024 A. Cremaschi, G. DEL SINDACO, A. Pagnano, A. Dolci, J. Berkenou, A. Rothenbuhler, A. Contarino, E. Ferrante, M. Arosio, E. Giannetta, A. Linglart, G. Mantovani
Inflammation-based scores in a large cohort of adrenocortical carcinoma and adrenocortical adenoma: role of the hormonal secretion pattern
2024 A. Mangone, V. Favero, A. Prete, Y.S. Elhassan, M. Asia, R. Hardy, G. Mantovani, I. Chiodini, C.L. Ronchi
Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?
2024 G. Grassi, A. Ghielmetti, M. Zampogna, I. Chiodini, M. Arosio, G. Mantovani, C. Eller Vainicher
Targeted silencing of GNAS in a human model of osteoprogenitor cells results in the deregulation of the osteogenic differentiation program
2024 F.M. Elli, D. Mattinzoli, M. Ikehata, F. Bagnaresi, M.A. Maffini, G. Del Sindaco, A. Pagnano, C. Lucca, P. Messa, M. Arosio, G. Castellano, C.M. Alfieri, G. Mantovani
Testosterone therapy does not affect coagulation in male hypogonadism: a longitudinal study based on thrombin generation
2024 V. Lanzi, R. Indirli, A. Tripodi, M. Clerici, M. Bonomi, B. Cangiano, I. Petria, M. Arosio, G. Mantovani, E. Ferrante
Recurrence in acromegaly: two tertiary centers experience and review of the literature
2024 A. Cremaschi, E. Sala, E. Lavezzi, G. Carosi, G. Del Sindaco, A. Mangone, R. Mungari, A. Pagnano, R. Indirli, E. Ferrante, G. Mazziotti, M. Locatelli, G. Lasio, M. Arosio, A.G. Lania, G. Mantovani
Response to: Letter to the Editor from Fitzpatrick et al: Zoledronate after denosumab discontinuation: Is repeated administrations more effective than single infusion?
2024 G. Grassi, A. Ghielmetti, M. Zampogna, I. Chiodini, M. Arosio, G. Mantovani, C. Eller-Vainicher
Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database
2024 F. Marini, G. Marcucci, F. Giusti, E. Arvat, S. Benvenga, M. Bondanelli, L. Castellino, V. Camozzi, S. Corbetta, M.V. Davì, F. Famà, D. Ferone, M. Iacobone, P. Loli, G. Mantovani, U. Pagotto, L. Persani, G. Perigli, A. Piovesan, A. Repaci, R.M. Ruggeri, C. Eller-Vainicher, L. Vera, M.C. Zatelli, G. Zavatta, M.L. Brandi
Resistance to somatostatin analogs in Italian acromegaly patients: the MISS Study
2023 A. Maria Berton, N. Prencipe, L. Bertero, M. Baldi, C. Bima, M. Corsico, A. Bianchi, G. Mantovani, F. Ferraù, P. Sartorato, I. Gagliardi, E. Ghigo, S. Grottoli
SCARB1 downregulation in adrenal insufficiency with Allgrove syndrome
2023 G. Bitetto, G. Lopez, D. Ronchi, A. Pittaro, V. Melzi, E. Peverelli, F.M. Cribiù, G.P. Comi, G. Mantovani, A. Di Fonzo
Aspetti neuropsicologici dell’eccesso di GH
2023 E. Sala, G. Mantovani
Estimation of the reference values and decision limits for growth hormone in newborns using dried blood spots
2023 M. Vidali, F. Giacchetti, A. Sangiorgio, C. Vantaggiato, G. Rodari, C. Orsenigo, A. Di Modugno, F. Napolitano, D. Morniroli, L. Colombo, E. Profka, G. Vizzari, F. Mosca, F. Ceriotti, G. Mantovani, M. Arosio, M.L. Giannì, C. Giavoli
Long-term outcome of thyroid abnormalities in patients with severe Covid-19
2023 I. Muller, A. Daturi, M. Varallo, T.E. Re, D. Dazzi, S. Maioli, E. Crivicich, F. Di Marco, V. Longari, B. Dazzi, M. Castellani, G. Mantovani, M. Arosio, M. Salvi
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
2023 G. Di Muro, F. Mangili, E. Esposito, A.M. Barbieri, R. Catalano, D. Treppiedi, G. Marra, E. Nozza, A.G.A. Lania, E. Ferrante, M. Locatelli, M. Arosio, E. Peverelli, G. Mantovani
Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas
2023 V. Morelli, F.M. Elli, S. Frigerio, W. Vena, S. Palmieri, C. Lucca, M.A. Maffini, A. Contarino, F. Bagnaresi, G. Mantovani, M. Arosio
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors
2023 G. Fiore, G.A. Bertani, G. Conte, E. Ferrante, L. Tariciotti, E. Kuhn, L. Runza, M. Pluderi, S. Borsa, M. Caroli, E. Sala, G. Platania, K. Kremenova, S. Ferrero, F.M. Triulzi, G. Mantovani, M. Locatelli
Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency
2023 S. Frigerio, G. Carosi, E. Ferrante, E. Sala, E. Polledri, S. Fustinoni, B. Ambrosi, I. Chiodini, G. Mantovani, V. Morelli, M. Arosio